Cancer & Drug Watch: AstraZeneca struck a $1.5B deal for Zegfrovy (sunvozertinib), an oral EGFR exon 20–mutated lung cancer therapy approved in the US and China, aiming to bolster its oncology pipeline. Public Health & Nutrition: A new study links higher sugar intake in early childhood with later-life risk of multiple cancers, including liver and bowel cancer, raising questions about toddler diet habits. Sleep & Gut Health: Small research from China reports fecal microbiota transplant “capsules” improved chronic insomnia in adults, pointing to the gut microbiome as a possible sleep lever. Healthcare Policy (China): China’s draft medical security law is set to add long-term care insurance provisions, as officials also report expanded medical fee waivers amid healthcare reform. Aging & Lifestyle: A feature on Rugao, China’s “World Longevity Town,” highlights daily routines tied to healthy aging, from tai chi to family meals. Global Health Systems: China’s world-first custom plant immunity system is being promoted for epidemic response, alongside coverage of digital health and AI-enabled healthcare cooperation. Medical Workforce (China): Reports highlight rising healthcare workforce capacity and ongoing barriers for women in the sector. Clinical Research: Multiple reviews and studies focus on hypertension self-care, sepsis triage, COPD frailty links, and imaging tools—signaling continued momentum in practical care improvements. Maritime Health Emergency: India and China-linked crews are involved in rescue efforts after a China-bound cargo ship sank in the Bay of Bengal, with medical care for rescued Chinese nationals.